LRRK2 and Parkinson disease: As many previous studies have relied on cellular models overexpressing LRRK2 or peripheral tissues from in vivo models, it remains unclear the degree to which variants in LRRK2 affect its kinase activity in the CNS or the extent to which its activity is increased in PD patients.